2008). Relentless progression of neurological

deterioration continues even in XPA patients who avoid sun exposure. Although atypical cases with mild neurological complications have been reported (Robbins et al. 1991; Anttinen et al. 2008), the most of XPA patients follow a similar clinical course in which they gradually deteriorate from having neurological symptoms in Quizartinib ic50 childhood to being bedridden in adulthood (Robbins et al. 1991). The pathogenesis of neuronal injury in XPA is still unclear and there are no treatments available. Pathological studies on autopsy brain were performed in a few XPA patients who reached adulthood (Kanda et al. 1990; Itoh et al. 1999), and revealed extensive Inhibitors,research,lifescience,medical loss of neurons and gliosis of the white matter in the central nervous system (CNS). Only Inhibitors,research,lifescience,medical few studies evaluated CNS involvement of XPA patients using head computed tomography, electroencephalography, or cognitive function testing (Mimaki et al. 1989; Robbins et al. 1991; Anttinen et al. 2008). There have been no reports on detailed

magnetic resonance imaging (MRI) analysis of pediatric XPA patients. In this preliminary study, we analyzed brain disorders in XPA patients using several MRI sequences. Subjects and Methods Ten genetically Inhibitors,research,lifescience,medical proven Japanese XPA patients were studied (Table 1). All patients had history of severe sunburn at the first sun exposure after birth and were diagnosed on the basis of the clinical episode and measurement of the minimal erythema dose. Most patients, except for No.7 and No.10, were genetically determined as having mutation c.390–1G>C Inhibitors,research,lifescience,medical in XPA by polymerase chain reaction restriction fragment length polymorphism using restriction enzyme AlwNI according to a previously described method (Nishigori et al. 1994). Each patient underwent neurological examination Inhibitors,research,lifescience,medical by an established neurologist and imaging studies on the same day. Images were obtained using a whole-body 3-Tesla MRI system (Phillips Medical Systems, Eindhoven, The Netherlands). Table

1 Neurological examinations and 3-Tesla MRI results in 10 Japanese XPA patients At first, we performed conventional sequences including T1-weighted images (T1WI) (echo time (TE) = 3.3 msec, repetition time (TR) = 7.2 msec, flip angle = 8°, field of view (FOV) = 256 × 256 mm2, matrix = 512 × 512, slice Tolmetin thickness (ST) = 0.8 mm), T2-weighted images (T2WI) (TE = 120 msec, TR = 3500 msec, flip angle = 90°, FOV = 230 × 230 mm2, matrix = 512 × 512, ST = 5.0 mm), and fluid-attenuated inversion recovery (FLAIR) imaging (TE = 125 msec, TR = 11000 msec, flip angle = 90°, FOV = 230 × 230 mm2, matrix = 512 × 512, ST = 5.0 mm). Next, we performed diffusion tensor imaging (DTI) (TE = 80 msec, TR = 8052 msec, flip angle = 90°, FOV = 256 × 256 mm2, matrix = 128 × 128, ST = 2.